• Consortium comprising Genesis Capital and WHSP Holdings proposes to acquire Monash IVF
• Revised offer price of $0.90 per share, up from previous $0.80 per share
• Proposal subject to conditions including exclusivity, transaction documentation, and Board recommendation

Monash IVF Group Limited (ASX: MVF) has received a revised, unsolicited, conditional and non-binding indicative proposal from a consortium comprising Genesis Capital Investment Management Pty Ltd and WHSP Holdings Pty Limited to acquire 100% of the shares in Monash IVF by way of a Scheme of Arrangement. The indicative cash price offered to shareholders under the revised proposal is $0.90 per share, up from the previous offer of $0.80 per share. The proposal is subject to a number of conditions, including exclusive due diligence, negotiation and execution of transaction documentation, unanimous recommendation of the Monash IVF Board, and final internal approval from the relevant Consortium Members. As at 24 November 2025, the Consortium holds an interest in approximately 19.6% of the ordinary shares in Monash IVF. The Monash IVF Board is assessing the proposal, including obtaining advice from its financial and legal advisers. Shareholders do not need to take any action in relation to the proposal, and there is no certainty that the discussions with the Consortium will result in any transaction.